Guobang Pharma Ltd
医疗健康 · 专科与仿制药
Guobang Pharma Ltd. engages in the research, development, production, and sale of products in the pharmaceutical and veterinary industries. The company offers pharmaceutical products, including quinolones, macrolides, cephalosporins, characteristic APIs, preparations and accessories, and key pharmaceutical intermediates; and mobile protection APIs, kinetophoretic preparations, and feed additives. It sells its products approximately in 117 countries and regions worldwide. The company was founded in 1996 and is based in Xinchang, China.
MARKET 市值 12.01B CNY PE 15.5x
52W ¥14.25 – ¥20.82
EODHD · Q 2026-03-31 · 同步 2026-07-14
QUALITY PEG — 营收 YoY 5.6%
▲ ROE 9.0% 营业利润率 13.6% 净利润率 12.6%
ANALYST 股息率 2.85%